Compare SBI Healthcare Opportunities Fund vs UTI Healthcare Fund
SBI Healthcare Opportunities Fund
UTI Healthcare Fund
Risk
Very High
Very High
Rating
5.0
4.0
Min SIP Amount
₹500
₹500
Expense Ratio
1.99
2.21
NAV
₹525.14
₹344.41
Fund Started
04 Jun 1999
01 Aug 2005
Fund Size
₹5796.42 Cr
₹1443.57 Cr
Exit Load
Exit load of 0.50% if redeemed within 15 days
Exit load of 1% if redeemed within 30 days.
1 Year
21.24%
16.98%
3 Year
23.33%
23.35%
5 Year
17.52%
15.23%
Equity
98.31%
97.08%
Cash
1.64%
2.90%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.72% |
Divi's Laboratories Ltd. | 7.46% |
Acutaas Chemicals Ltd. | 5.17% |
Cipla Ltd. | 5.07% |
Apollo Hospitals Enterprise Ltd. | 4.98% |
Torrent Pharmaceuticals Ltd. | 4.74% |
Max Healthcare Institute Ltd. | 4.58% |
Laurus Labs Ltd. | 4.04% |
Aurobindo Pharma Ltd. | 3.86% |
Aster DM Quality Care Ltd. | 3.65% |
Sun Pharmaceutical Industries Ltd. | 8.71% |
Divi's Laboratories Ltd. | 5.57% |
Ajanta Pharma Ltd. | 4.80% |
Caplin Point Laboratories Ltd. | 3.95% |
Lupin Ltd. | 3.59% |
Gland Pharma Ltd. | 3.56% |
Apollo Hospitals Enterprise Ltd. | 3.46% |
Dr. Reddy's Laboratories Ltd. | 3.10% |
Alkem Laboratories Ltd. | 3.10% |
Global Health Ltd. | 2.81% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
04 Jun 1999
01 Aug 2005
